Chembio Diagnostic Systems, Inc. Company Profile

08:45 EST 13th December 2018 | BioPortfolio

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Chembio’s focus is on developing, manufacturing and marketing tests for the rapid, simple and cost-effective detection of HIV, Tuberculosis (human and veterinary), and certain other Neglected Diseases. Chembio has a proven commitment toward ensuring sustainable supplies of high quality rapid tests to those who need them by using innovative, socially responsible strategies. Chembio Diagnostic Systems, Inc. operates a cGMP/QS (Good Manufacturing Facility/Quality Systems) manufacturing facility that is registered with the US FDA (Food and Drug Administration). The facility includes dedicated cGMP process manufacturing, Quality Control and R&D laboratories. The company manufacturers class II and class III in vitro diagnostic devices. Chembio ’s HIV assays have been incorporated into the World Health Organization (WHO) Bulk Procurement Scheme and the USAID blanket Waiver List which allows them to be procured with US government funds. In 2006, Former President Bill Clinton announced that his foundation’s HIV/AIDS Initiative negotiated new pricing agreements to lower the prices of HIV diagnostics and two antiretrovirals (ARVs). These products and pricing include Chembio’s STAT-PAK™ HIV 1 / 2 Dipstick. The Foundation’s Procurement Consortium currently includes 50 developing countries around the world.


3661 Horseblock Road
New York
United States of America


Phone: 1 631 924 1135
Fax: 1 631 924 6033

News Articles [839 Associated News Articles listed on BioPortfolio]

Chembio Dx appoints new board member

Mary Lake Polan, a professor at the Yale School of Medicine, has been tapped by Chembio Diagnostic Systems to serve on its bo -More- 

FIND, Chembio partner to explore point-of-care HCV testing

Chembio Diagnostic Systems' Dual Path Platform technology will be used to assess the feasibility of a rapid hepatitis C virus -More- 

FDA grants emergency use authorization for Chembio's Ebola test

Chembio Diagnostic Systems' DPP Ebola Antigen System is the second rapid antigen fingerstick test granted emergency use autho -More- 

Chembio nets $15mm via FOPO

Infectious disease-focused Chembio Diagnostics Inc. netted $15mm through a registered public offering of 2.37mm common shares at $6.75. Chembio will use the proceeds to fund its proposed $5.5mm acquis...

Chembio secures FDA EUA authorization for Ebola virus diagnostic test

Chembio said the EUA status has been provided for the DPP Ebola antigen system for use with human capillary fingerstick whole blood, EDTA venous whole blood and EDTA The post Chembio secures FDA EUA ...

Chembio to buy OpTricon for $5.5M, commences $25M offering

Chembio Diagnostics will pay $5.5 million in cash for Germany-based OpTricon, which makes handheld analyzers for rapid diagno -More- 

Chembio Dx announces pricing of stock offering

A public offering of approximately 2.4 million shares of common stock has been priced by Chembio Diagnostics at $6.75 each.  -More- 

Chembio Diagnostic Inc CEMI Financial and Strategic SWOT Analysis Review [Report Updated: 31072018] Prices from USD $125

Chembio Diagnostic Inc CEMI Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by G...

Drugs and Medications [24 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Oxygen Support Systems Inc]


Derma ice burn relief with aloe vera [S & S Primeline Chemical Systems]


Oxygen [Medical Comfort Systems Inc]

Oxygen Label

Xenon xe 133 gasfor diagnostic use [Bristol-Myers Squibb]


Glucagen hypokit [Novo Nordisk]

These highlights do not include all the information needed to use GlucaGen safely and effectively. See full prescribing information for GlucaGen.GlucaGen  (glucagon [rDNA origin] for injection)Initia...

PubMed Articles [2001 Associated PubMed Articles listed on BioPortfolio]

The diagnostic and cellularity yield of reverse bevel versus fork-tip fine needle biopsy.

Two new systems with a novel tip (Procore™ and SharkCore™) have been introduced for ultrasound-guided fine needle biopsy (US-FNB). Direct comparison of the diagnostic yield of these needles in the...

Teaching about diagnostic errors through virtual patient cases: a pilot exploration.

Diagnostic error is a major problem in health care, yet there are few medical school curricula focused on improving the diagnostic process and decreasing diagnostic errors. Effective strategies to tea...

Mind the overlap: how system problems contribute to cognitive failure and diagnostic errors.

Background Traditionally, research has examined systems- and cognitive-based sources of diagnostic error as individual entities. However, half of all errors have origins in both domains. Methods We co...

Mortality and morbidity rounds (MMR) in pathology: relative contribution of cognitive bias vs. systems failures to diagnostic error.

Background Heuristics and cognitive biases are thought to play an important role in diagnostic medical error. How to systematically determine and capture these kinds of errors remains unclear. Morbidi...

Understanding the severity of depression: Which symptoms of depression are the best indicators of depression severity?

In DSM-5, all symptoms of depression are considered equal representations of severity. In ICD-10, the type of symptom is considered in classifying severity. It is important to better understand if the...

Clinical Trials [3351 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in ...

Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps

Several novel imaging technologies are currently used for detection and differentiation of colonic polyps during colonoscopy, such as NBI (Olympus), FICE (Fujinon), and i-Scan (Pentax). ...

Medical Evaluation of Scanner in Coronary Syndrome

Many recent publications have reported encouraging results on diagnostic cardiac multislice CT performance in 1) coronary artery disease, 2) coronary arterial bypass graft potency and 3) i...

Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems

To compare two intrauterine systems in order to avoid complications originating from short pregnancy interval and undesired pregnancies in the early postpartum period.

Companies [2407 Associated Companies listed on BioPortfolio]

Chembio Diagnostic Systems Incorporated

Chembio Diagnostic Systems, Inc., is a U.S. biotechnology company located in Medford, New York. The company discovers, develops, manufactures and markets rapid immunodiagnostic tests. Chembio's rapid ...

Chembio Diagnostics

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Ch...

Chembio Diagnostic Systems, Inc.

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Ch...

Natus Medical

Natus' product lines include: Hearing Screening Systems, Hearing Diagnostic Systems, Jaundice Management Products, Newborn Care Products, Data Management Systems, Neurology Diagnostic Systems and Slee...

ONI Medical Systems Inc.

ONI Medical Systems Inc. has developed and marketed dedicated-purpose musculoskeletal MRI systems that exceed the rigorous requirements of diagnostic radiology. With a clear focus...

More Information about "Chembio Diagnostic Systems, Inc." on BioPortfolio

We have published hundreds of Chembio Diagnostic Systems, Inc. news stories on BioPortfolio along with dozens of Chembio Diagnostic Systems, Inc. Clinical Trials and PubMed Articles about Chembio Diagnostic Systems, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chembio Diagnostic Systems, Inc. Companies in our database. You can also find out about relevant Chembio Diagnostic Systems, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...

Corporate Database Quicklinks

Searches Linking to this Company Record